BREAKING NEWS

PharmaMar aims to start phase III trial of cancer drug for COVID-19

By REUTERS

OCTOBER 16, 2020 11:11

Spanish pharmaceutical company PharmaMar said on Friday a clinical trial of its cancer drug Aplidin to treat adult patients with COVID-19 had achieved its safety and efficacy goals and it aimed to start phase III trials.

PharmaMar shares rose 4.4% in morning trading.

The company said there was a substantial reduction in viral load and the C-reactive protein (CRP) in patients, and that 80.7% of the patients had been discharged before the 15th day of hospitalization, and 38.2% before the 8th day.

"With these data, the company will begin, in the next few days, conversations with the regulatory agencies to define the next phase III pivotal study for plitidepsin (Aplidin) in patients with COVID-19, who require hospitalization," PharmaMar said in a statement.

Ukraine's drone attack sparks industrial fire in Russia's Kaluga

By REUTERS

11/25/2024 01:29 AM

White House condemns murder of Chabad emissary Zvi Kogan

By JERUSALEM POST STAFF

11/25/2024 01:26 AM

IDF announces military exercise to take place in Eilat area on Monday

By JERUSALEM POST STAFF

11/24/2024 10:41 PM

Iran Embassy in UAE rejects Iran's involvement in Rabbi's murder

By JERUSALEM POST STAFF

11/24/2024 10:07 PM